Live-imaging rate-of-kill compound profiling for Chagas disease drug discovery with a new automated high-content assay.
Chagas disease, caused by the protozoan intracellular parasite Trypanosoma cruzi, is a highly neglected tropical disease, causing significant morbidity and mortality in central and south America. Current treatments are inadequate, and recent clinical trials of drugs inhibiting CYP51 have failed, exp...
Enregistré dans:
Auteurs principaux: | Nina Svensen, Susan Wyllie, David W Gray, Manu De Rycker |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0428e734a42f4d65a9fe295ff74ee419 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box.
par: Juan Cantizani, et autres
Publié: (2021) -
The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species.
par: J Mark F Gardner, et autres
Publié: (2021) -
The costs of preventing and treating chagas disease in Colombia.
par: Marianela Castillo-Riquelme, et autres
Publié: (2008) -
A novel substrate for arrhythmias in Chagas disease.
par: Artur Santos-Miranda, et autres
Publié: (2021) -
Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.
par: Maha-Hamadien Abdulla, et autres
Publié: (2009)